Outstanding outcomes in infants with <i>KMT2A</i>-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial-Reference-Cited by-同舟云学术

Outstanding outcomes in infants with <i>KMT2A</i>-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial

Published:2022-02-17 Issue:5 Volume:107 Page:1205-1208
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Guest Erin M.,Kairalla John A.,Hilden Joanne M.,Dreyer ZoAnn E.,Carroll Andrew J.,Heerema Nyla A.,Wang Cindy Y.,Devidas Meenakshi,Gore Lia,Salzer Wanda L.,Winick Naomi J.,Carroll William L.,Raetz Elizabeth A.,Borowitz Michael,Loh Mignon L.,Hunger Stephen P.,Brown Patrick A.

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Reference14 articles.

1. Dreyer ZE, Hilden JM, Jones TL. Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3). Pediatr Blood Cancer. 2015; 62(3):419-426.

2. Pieters R, De Lorenzo P, Ancliffe P. Outcome of infants younger than 1 year with acute lymphoblastic leukemia treated with the Interfant-06 protocol: results from an international phase III randomized study. J Clin Oncol. 2019; 37(25):2246-2256.

3. Pieters R, Schrappe M, De Lorenzo P. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007; 370(9583):240-250.

4. Hilden JM, Dinndorf PA, Meerbaum SO. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. Blood. 2006; 108(2):441-451.

5. Tomizawa D, Miyamura T, Imamura T. A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial. Blood. 2020; 136(16):1813-1823.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KMT2A Rearrangements in Leukemias: Molecular Aspects and Therapeutic Perspectives;International Journal of Molecular Sciences;2024-08-20

2. Infant Acute Lymphoblastic Leukemia—New Therapeutic Opportunities;International Journal of Molecular Sciences;2024-03-27

3. Cytogenetics and genomics in pediatric acute lymphoblastic leukaemia;Best Practice & Research Clinical Haematology;2023-12

4. Children's Oncology Group blueprint for research: Acute lymphoblastic leukemia;Pediatric Blood & Cancer;2023-07-25

5. Minimal residual disease predicts outcomes in KMT2A‐rearranged but not KMT2A‐germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631;Pediatric Blood & Cancer;2023-05-31